Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The interleukin-1 axis and cutaneous inflammation

T S Kupper1, R W Groves

  • 1Division of Dermatology, Harvard Skin Disease Research Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

The Journal of Investigative Dermatology
|July 1, 1995
PubMed
Summary

Interleukin-1 (IL-1) alpha and beta play key roles in skin disease pathogenesis. Their activity is tightly regulated by specific receptor antagonists and binding proteins, influencing biological outcomes in skin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigus.

Journal of the American Academy of Dermatology·2026
Same author

Sporadic pemphigus foliaceus and class II human leucocyte antigen allele associations in the white British and Indo-Asian populations in the UK.

Clinical and experimental dermatology·2018
Same author

British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.

The British journal of dermatology·2017
Same author

Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.

Clinical and experimental dermatology·2016
Same author

Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis.

Clinical and experimental dermatology·2016
Same author

Outcome assessment in cellulitis clinical trials: is telephone follow up sufficient?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015

Area of Science:

  • Immunology
  • Dermatology
  • Molecular Biology

Background:

  • Interleukin-1 (IL-1) alpha and beta, discovered to be identical to epidermal cell-derived thymocyte-activating factor in 1986, are implicated in skin disease pathogenesis.
  • IL-1 activity is regulated by a complex system involving gene products that modulate its signaling pathway.
  • Keratinocytes possess the capability to produce these regulatory factors in vitro.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of IL-1 activity in the skin.
  • To understand the roles of IL-1 agonists and antagonists in cutaneous biology.
  • To establish the utility of transgenic mouse models for studying IL-1's cutaneous functions.

Main Methods:

  • Investigating the binding of IL-1 alpha and mature IL-1 beta to the type 1 IL-1 receptor.

Related Experiment Videos

  • Analyzing the antagonistic effects of IL-1 receptor antagonists and type 2 IL-1 receptors on IL-1 signaling.
  • Utilizing in vitro keratinocyte cultures to study the production of IL-1 regulatory factors.
  • Proposing the use of transgenic mice overexpressing individual IL-1 regulatory factors in the epidermis.

    • Main Results:

    • IL-1 alpha and mature IL-1 beta signal through the type 1 IL-1 receptor.
    • Two forms of IL-1 receptor antagonist inhibit IL-1 signaling by binding to the type 1 receptor without signal transduction.
    • Type 2 IL-1 receptor, both cell-bound and soluble, antagonizes IL-1 by binding the ligand without signal transduction.
    • The balance between IL-1 agonists and antagonists in keratinocytes determines the biological outcome of IL-1-mediated events.

    Conclusions:

    • The biological outcome of IL-1-mediated events in the skin is dictated by the balance between IL-1 agonists and antagonists.
    • Understanding the intricate regulation of IL-1 activity is crucial for comprehending skin disease pathogenesis.
    • Transgenic mouse models overexpressing IL-1 regulatory factors are valuable tools for advancing the study of cutaneous IL-1 biology.